Vendor capability gaps and failed implementations erode sponsor trust, while complex neurocognitive instruments can be ...
In this video interview, Sam Hinsley, statistics manager at Phastar, introduces the Early Phase ESIG, a new special interest ...
In a recent video interview with Applied Clinical Trials, Sam Hinsley, statistics manager at Phastar, discussed the critical ...
ACT Brief: Clinical Development Orchestration, Career Insights in Trials, and FDA Communication Gaps
In today's ACT Brief, we examine how program-level orchestration is becoming critical to R&D success, reflections on ...
In today's ACT Brief, we examine operational RBQM enhanced by AI, how statisticians ensure responsible data use across ...
Agentic AI can achieve >80% precision in discrepancy detection, enabling depth-first listing review that reduces variability, ...
Late-stage productivity improved in 2025, but total clinical development duration rose to 10 years, indicating non-structural ...
In this video interview, Sam Hinsley, statistics manager at Phastar, reflects on why she chose a career in clinical trials ...
In this conversation between Rebecca Johnson, PhD, ACT EAB member and clinical research recruitment and inclusion executive ...
In today's ACT Brief, we explore how diversity is embedded across trial planning at Merck, integration of patient-reported ...
In today's ACT Brief, we examine leadership instability and regulatory uncertainty during Makary's FDA tenure, how lived ...
For years, the clinical trial industry has been sold an appealing idea: participant adherence is largely a problem that can ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results